PROJECT SUMMARY
Edited magnetic resonance spectroscopy allows the non-invasive detection of low-concentration
metabolites within the brain, free from overlap from other, more abundant compounds. Until recently, spectral-
editing techniques have generally focused on measuring individual metabolites in one brain region at a time
(for instance, the well-known ‘MEGA-PRESS’ method). However, this is a time-consuming approach which
severely limits clinical applicability when multiple metabolites and/or brain regions are involved. The main goal
of this proposal is therefore to develop and establish the reproducibility edited experiments that can detect
multiple edited molecules in multiple brain regions, all within a single acquisition.
We will develop multi-voxel localization techniques to combine with our recently developed multi-metabolite
editing methods, including the Hadamard-encoded ‘HERMES’ approach as well as the new ‘HERCULES’
method which allows for up to 13 metabolites to be simultaneously determined. For applications that may
require a limited number of voxels to be acquired, we will developed multi-band excitation and parallel
acquisition ‘PRIAM’ methods in combination with HERMES and HERCULES. For applications that require
greater spatial coverage and/or the ability to map out the spatial distribution of metabolite levels, edited MR
spectroscopic imaging (MRSI) techniques will be developed for use in combination with HERMES and
HERCULES editing. Since edited-MRSI is very sensitive to head motion and other instabilities, acquisition and
processing methods will be implemented for robust, motion-insensitive edited-MRSI.
Rigor and reproducibility will be carefully assessed; newly developed methodologies will be validated by
comparison to conventional measurements in the same subjects. Expected improvements in temporal signal-
to-noise ratios and reproducibility will also be measured. The resulting data acquisition and analysis tools will
be made available for dissemination to the clinical neuroscience and neuroimaging communities.
Public Health Relevance Statement
PROJECT NARRATIVE
Magnetic resonance spectroscopy (MRS) can measure the concentration of naturally occurring chemicals
within the brain, often applying ‘edited’ methods which focus on one particular chemical and location. This
project will develop new experimental methods that allow the simultaneous measurement of several chemicals
simultaneously in multiple regions of the brain. The methods developed in this study will be disseminated to the
neuroimaging community, and are expected to have a wide range of clinical and neuroscience applications.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
001910777
UEI
FTMTDMBR29C7
Project Start Date
15-April-2020
Project End Date
31-October-2025
Budget Start Date
01-November-2023
Budget End Date
31-October-2025
Project Funding Information for 2024
Total Funding
$404,382
Direct Costs
$284,614
Indirect Costs
$119,768
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$404,382
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB028259-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB028259-04
Patents
No Patents information available for 5R01EB028259-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB028259-04
Clinical Studies
No Clinical Studies information available for 5R01EB028259-04
News and More
Related News Releases
No news release information available for 5R01EB028259-04
History
No Historical information available for 5R01EB028259-04
Similar Projects
No Similar Projects information available for 5R01EB028259-04